ARDIZZONE, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 23.591
NA - Nord America 16.882
AS - Asia 15.544
SA - Sud America 1.469
AF - Africa 276
OC - Oceania 151
Continente sconosciuto - Info sul continente non disponibili 20
Totale 57.933
Nazione #
US - Stati Uniti d'America 16.349
GB - Regno Unito 9.397
CN - Cina 5.134
IT - Italia 4.703
SG - Singapore 4.511
DE - Germania 2.270
RU - Federazione Russa 1.428
SE - Svezia 1.377
HK - Hong Kong 1.224
BR - Brasile 1.005
VN - Vietnam 960
IN - India 832
FR - Francia 831
NL - Olanda 635
UA - Ucraina 631
TR - Turchia 620
BD - Bangladesh 619
IE - Irlanda 573
KR - Corea 515
FI - Finlandia 445
CA - Canada 344
JP - Giappone 331
ES - Italia 326
EU - Europa 250
CO - Colombia 218
ID - Indonesia 195
PL - Polonia 177
DK - Danimarca 146
BE - Belgio 123
AU - Australia 117
AR - Argentina 101
MX - Messico 96
CI - Costa d'Avorio 82
GR - Grecia 81
IQ - Iraq 76
CH - Svizzera 75
AT - Austria 69
SA - Arabia Saudita 52
TW - Taiwan 47
UZ - Uzbekistan 47
PT - Portogallo 46
RO - Romania 45
PK - Pakistan 42
AE - Emirati Arabi Uniti 37
EC - Ecuador 36
IL - Israele 35
IR - Iran 35
PH - Filippine 35
ZA - Sudafrica 35
MA - Marocco 33
CZ - Repubblica Ceca 30
HU - Ungheria 30
CL - Cile 28
NZ - Nuova Zelanda 28
JO - Giordania 27
VE - Venezuela 27
NO - Norvegia 26
EG - Egitto 22
MY - Malesia 20
LU - Lussemburgo 18
PE - Perù 17
TH - Thailandia 17
JM - Giamaica 16
PY - Paraguay 16
DZ - Algeria 15
KE - Kenya 15
LK - Sri Lanka 15
NP - Nepal 15
AZ - Azerbaigian 14
BO - Bolivia 14
LB - Libano 14
LT - Lituania 14
SK - Slovacchia (Repubblica Slovacca) 13
TN - Tunisia 13
CR - Costa Rica 11
KZ - Kazakistan 11
PR - Porto Rico 10
RS - Serbia 10
BG - Bulgaria 9
AL - Albania 8
BY - Bielorussia 8
HR - Croazia 8
KG - Kirghizistan 8
LV - Lettonia 7
MO - Macao, regione amministrativa speciale della Cina 7
SN - Senegal 7
TT - Trinidad e Tobago 7
BA - Bosnia-Erzegovina 6
DO - Repubblica Dominicana 6
HN - Honduras 6
MD - Moldavia 6
NI - Nicaragua 6
OM - Oman 6
SI - Slovenia 6
CY - Cipro 5
ET - Etiopia 5
KH - Cambogia 5
NG - Nigeria 5
PA - Panama 5
QA - Qatar 5
Totale 58.038
Città #
Southend 8.746
Singapore 2.663
Ashburn 1.762
Chandler 1.289
Hong Kong 1.143
Beijing 1.045
Milan 987
San Jose 901
Dallas 695
Seattle 693
Frankfurt am Main 657
Princeton 623
Wilmington 592
Jacksonville 558
Dublin 557
Council Bluffs 478
Santa Clara 469
Fairfield 416
Los Angeles 397
Ann Arbor 378
Bengaluru 341
Dearborn 339
Nanjing 338
Hangzhou 336
Houston 327
New York 312
Redmond 301
Woodbridge 301
Ho Chi Minh City 278
Rome 278
Lauterbourg 270
Munich 265
Boardman 260
Hanoi 255
Guangzhou 251
Somerville 234
Redwood City 220
Des Moines 213
Buffalo 202
Shanghai 198
Serra 195
Mountain View 193
Moscow 184
Bogotá 177
Andover 176
Sakarya 168
Toronto 164
Helsinki 154
Tokyo 150
Phoenix 147
Hefei 144
Cambridge 132
Berlin 124
Warsaw 120
São Paulo 109
Jinan 106
Jakarta 100
Tianjin 100
Cangzhou 94
Nanchang 94
Shenyang 94
Istanbul 90
The Dalles 90
Turin 84
Abidjan 82
Columbus 82
Grafing 78
Changsha 75
Chicago 75
Fuzhou 73
Turku 72
Seoul 67
Naples 64
Hebei 62
Brussels 61
London 61
Wuhan 60
Hanover 59
Shenzhen 58
San Diego 56
Palermo 55
Madrid 54
Sunnyvale 54
Bitonto 53
Bologna 53
Verona 52
Amsterdam 49
Stockholm 49
Da Nang 47
Nuremberg 47
Paris 47
Montreal 46
Mumbai 46
Zhengzhou 46
Barcelona 44
Fremont 43
Jiaxing 43
Kunming 42
Florence 39
Genoa 39
Totale 35.790
Nome #
Validation of the Italian translation of the Inflammatory bowel disease questionnaire 1.683
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial 1.187
Inflammatory bowel disease phenotype as risk factor for cancer in a prospective multicentre nested case-control IG-IBD Study 707
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior 645
Strictureplasties performed by laparoscopic approach for complicated Crohn's disease. A prospective, observational, cohort study 568
Autologous hematopoetic stem cell transplantation for refractory Crohn disease a randomized clinical trial 525
Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease : a review on behalf of ECCO and EBMT 502
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term results 489
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus 480
Small bowel carcinomas in coeliac or Crohn's disease: Clinico-pathological, molecular, and prognostic features : A study from the small bowel cancer Italian consortium 406
Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study 400
Increase in chromogranin A- and serotonin-positive cells in pouch mucosa of patients with ulcerative colitis undergoing proctocolectomy 400
Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent: analysis of results and predictors of outcomes in a large multicenter series 391
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 371
Certolizumab pegol : an evidence-based review of its place in the treatment of Crohn’s disease 369
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 349
Adalimumab in active ulcerative colitis: A "real-life" observational study 347
Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease 330
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease 307
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool 298
Autologous haematopoietic stem cell transplantation for refractory Crohn's disease : up to 2 year follow up without CD34+ cell selection 293
Noninvasive testing in the management of children with suspected inflammatory bowel disease 284
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years : An Italian multicentre study 275
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease : Special situations 273
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 266
Endoscopic retrograde cholangiopancreatography, lights and shadows: Handle with care 261
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on Th1/Th2 cytokines in inflammatory bowel disease : an in vitro study 256
Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease 255
Prevalence, detection rate and outcome of Cytomegalovirus infection in ulcerative colitis patient requiring colonic resection 253
The PROSit cohort of infliximab biosimilar in IBD : a prolonged follow-up on the effectiveness and safety across Italy 253
Inflammatory colitis: classification and surgical treatment 250
Ultrasonographic detection of toxic megacolon in inflammatory bowel diseases 245
Strictureplasty and bowel resection in complicated Crohn's disease. A prospective comparative study on morbidity and long-term recurrence 245
Sympathetic overactivity in active ulcerative colitis: Effects of clonidine 245
Serum protein profiling of early and advanced stage Crohn's disease 244
Infliximab-induced lupus in Crohn's disease: a case report 243
CARD15 gene variants and risk of reoperation in Crohn's disease patients 240
Trombofilia e malattie infiammatorie croniche intestinali 239
Azathioprine and mesalamine in preventing relapse after conservative surgery for Crohn's disease : results of randomized controlled trial 239
L'ecografia intestinale nel morbo di Crohn. Rilevanza chirurgica 236
Anal endosonographic evaluation of infliximab treatment for perianal fistulizing Crohn's disease 236
Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis : a prospective study in an open access endoscopy service 234
Terapia medica della colite ulcerosa refrattaria 233
Use of colonoscopy in the management of patients with Crohn's disease: appropriateness and diagnostic yield 233
An evolutionary analysis of RAC2 identifies haplotypes associated with human autoimmune diseases 233
The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis 232
Power Doppler sonography in the diagnosis of fistulae in complicated Crohn's disease 231
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement 230
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alfa treatment 227
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 227
MDR1 C3435T polymorphism and susceptibility to inflammatory bowel disease : lack of association in an italian population 227
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease 227
Autologous haematopoietic unselected peripheral blood stem cell transplantation in refractory Crohn's disease: up to 2-years follow-up of a phase I-II trial 225
Contrast radiology, computed tomography (CT) and ultrasonography (US) in detecting abdominal complications of Crohn's disease (CD). A prospective comparative study 225
Morphological and functional evaluation of ileo-pouch-anal-anastomosis for ulcerative colitis by dynamic transperineal ultrasound 225
Ulcerative colitis : current pharmacotherapy and future directions 225
Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn's disease 224
Infliximab nel trattamento del pioderma gangrenoso nella colite ulcerosa cortico-dipendente 223
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 223
Acute obstruction in Crohn's disease . Results of a multidisciplinary prospective protocol for surgical management 222
Fok 1 vitamin D receptor gene polymorphism does not affect bone mineral density in patients with inflammatory bowel disease 222
Dermatological Manifestations in Inflammatory Bowel Diseases 221
Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohn's disease 220
Infliximab nel trattamento del morbo di Crohn fistolizzante : follow-up clinico ed endosonografico 220
Prevalence and clinical significance of sonographic alteration of mesenteric fat in Crohn's disease 219
L'anemia nelle malattie infiammatorie croniche intestinali 219
Prevalence of pancreatic insufficiency in inflammatory bowel diseases : assesment by fecal elastase-1 219
Age, and location, but not gender, behaviour, family history and extraintestinal manifestations affect recurrence after conservative surgery for complicated Crohn's disease 219
Autologous haematopoietic stem cell transplantation for refractory Crohn’s disease: updating the Milan experience without CD34+ cell selection 218
Fistole perianali nella malattia di Crohn : Un approccio pratico al trattamento 217
Morphological and functional evaluation of ileo-pouch-anal-anastomosis for ulcerative colitis by dynamic transperineal ultrasound 217
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 217
Non-conventional strictureplasty in Crohn's disease. Analysis of morbidity and long-term recurrence in a consecutive series of 102 patients. A prospective longitudinal study 216
Ruolo dei salicilati nella colite ulcerosa in remissione: prevenzione della recidiva o del cancro colo-rettale? 214
Autologous stem cell transplantation in moderate-severe refractory Crohn’s disease : the Milan experience without CD34+ cells selection 213
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 213
The impact of timing on the efficacy of foy in the prevention of acute pancreatitis : a randomised study comparing prior vs after-ERCP administration 212
Autologous non- myeloablative haematopoietic stem cell transplantation without CD34+selection for refractory Crohn's disease: the Milan experience after 5 years 212
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal 212
Multidrug resistance 1 gene polymorphism and susceptibility to inflammatory bowel disease 211
Efficacia dell'infliximab nel trattamento a breve termine del morbo di Crohn 211
Azathioprine is more effective than oral 5-ASA in the treatment of steroid-dependent ulcerative colitis 211
Virtual Chromoendoscopy With FICE for the Classification of Polypoid and Nonpolypoid Raised Lesions in Ulcerative Colitis 211
Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis : effect of antiviral treatment 209
Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis 209
Circulating fibroblast activation protein as potential biomarker in patients with inflammatory bowel disease 209
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease an IG-IBD study 208
Osteoporosi e malattie infiammatorie croniche intestinali: sorveglianza e terapia 208
A prospective, longitudinal study of nonconventional strictureplasty in Crohn's disease 208
Controlled trial of azathioprine and mesalamine in preventing recurrence after conservative surgery for Crohn's disease 208
Autoantibody profile during short-term infliximab treatment for Crohn's disease : a prospective cohort study 206
IBD Year Book 2001 206
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 206
Can bowel ultrasound replace colonoscopy in diagnosing ulcerative colitis flare-up and monitoring its response to medical therapy ? A prospective, endoscopic-controlled study 206
Efficacy, tolerability and outcome of antiviral therapy in patients affected by hepatitis C and inflammatory bowel disease 206
Biologic targeting in the treatment of inflammatory bowel diseases 206
Vitamin D and inflammatory bowel disease 206
Indications and diagnostic yield of double-balloon enteroscopy in Crohn's disease 205
Contrast-enhanced ultrasound in the diagnosis of intraabdominal inflammatory masses complicating Crohn's disease. A prospective comparison with computed tomography 205
Free IL-18 in Crohn's disease : is the target suitable for a therapeutic intervention with IL-18 binding protein? Validation of the expression of free IL-18 in sera of active patients 205
Totale 28.891
Categoria #
all - tutte 144.944
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.944


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.237 0 0 0 0 0 0 0 0 0 0 853 384
2021/20224.167 322 153 182 332 309 256 319 355 481 525 225 708
2022/20234.964 579 462 388 627 516 878 181 303 542 115 240 133
2023/20243.685 136 262 181 225 714 408 258 337 146 216 361 441
2024/20258.042 376 744 219 877 763 317 345 799 441 690 794 1.677
2025/202615.256 1.655 1.024 1.548 1.121 1.648 1.060 1.767 854 1.621 1.403 1.555 0
Totale 60.566